Abstract:A series of inhibitors of glucosylceramide synthesis, the PDMP based family of compounds, has been developed as a tool for the study of sphingolipid biochemistry and biology. During the course of developing more active glucosylceramide synthase inhibitors, we identified a second site of inhibitory activity for PDMP and its structural homologues that accounted for the ability of the inhibitors to raise cell and tissue ceramide levels. This inhibitory activity was directed against a previously unknown pathway for ceramide metabolism, viz. the formation of 1- O -acylceramide. In this pathway the addition of a fatty acyl group to the primary hydroxyl of ceramide occurs through a transacylation with either phosphatidylethanolamine or phosphatidylcholine as a substrate. However, both in the absence and presence of ceramide, water serves as an acceptor for the fatty acid. Thus the enzyme may be considered to be a phospholipase A2. The enzyme is unique in that it has an acidic pH optimum and is localized to lysosomes by cell fractionation. More recently, the 1- O -acylceramide synthase has been purified, sequenced, and cloned. This phospholipase A2 was discovered to be structurally homologous to lecithin cholesterol acyltransferase (LCAT). However, this phospholipase A2 does not recognize cholesterol and lacks the defined lipoprotein-binding domain present in LCAT. We now refer to this enzyme as lysosomal phospholipase A2 (LPLA2). Although acidic phospholipase A2 activities have been previously identified, LPLA2 appears to be the first lysosomal PLA2 to have been sequenced. This new phospholipase A2 lacks an obvious and proven biological function.

Investigations on the association of phosphatidylserine synthase with the ribosomal component from Escherichia coli

Phosphatidylserine transport by ORP/Osh proteins is driven by phosphatidylinositol 4-phosphate

A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity

Structural basis for catalysis and selectivity of phospholipid synthesis by eukaryotic choline-phosphotransferase

A protein network for phospholipid synthesis uncovered by a variant of the tandem affinity purification method in Escherichia coli

Metabolism and functions of phosphatidylserine

Structural insights into phosphatidylethanolamine N -methyltransferase PmtA mediating bacterial phosphatidylcholine synthesis

Sphingomyelin Synthase Related Protein is a Mammalian Phosphatidylethanolamine Phospholipase C

Insights into Membrane Association of the SMP Domain of Extended Synaptotagmin.

Binding-induced lipid domains: Peptide-membrane interactions with PIP2 and PS

Phosphatidylserine synthase I and II of mammalian cells

Interaction of protein kinase C with phosphatidylserine. 1. Cooperativity in lipid binding

Biophysical characterization of full-length oleosin in dodecylphosphocholine micelles

Phosphatidylserine biosynthesis pathways in lipid homeostasis: Toward resolution of the pending central issue for decades

Sensing Phosphatidylserine in Cellular Membranes

Aggregation of phospholipid vesicles induced by the ribosome inactivating protein saporin

Phosphatidylserine enrichment in the nuclear membrane regulates key enzymes of phosphatidylcholine synthesis

Distribution, dynamics and functional roles of phosphatidylserine within the cell

Phospholipid Preparations to Characterize Protein-Lipid Interactions In Vitro

Molecular insights into human phosphatidylserine synthase 1 reveal its inhibition promotes LDL uptake

CDS2 expression regulates de novo phosphatidic acid synthesis